NEW ORLEANS - Ochsner MD Anderson Cancer Center will be the first in the South to offer Biology-Guided Radiotherapy, joining ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Intent-to-treat median PFS was 10.2 months with nivolumab/ipilimumab versus 6.3 months with added SBRT, with 12-month PFS 47.8% versus 34.9% (HR 1.20; P=.56). Per-protocol analysis after four ...

At the 2026 Miami Breast Cancer Conference, Kevin Kalinsky, MD, MS, participated in a molecular tumor board session that brought together a multidisciplinary panel including medic ...

Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It's the most common cancer in women, excluding skin cancers.

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Radiation therapy remains one of the most important tools for treating cancer, but experts say patients receiving radiation near the chest should also be aware of potential long-term heart risks.

Particle therapy experts gathered in London to discuss the transformative potential of laser-driven proton and ion beams ...

OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.

The IU Health Cancer Center in Lafayette has earned a three-year gold seal accreditation in radiation oncology from the American College of Radiology.

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.